Bruker (NASDAQ: BRKR) reported Q3 EPS of $0.60, in-line with the analyst estimate of $0.60. Revenue for the quarter came in at $864.4 million versus the consensus estimate of $866.46 million.

GUIDANCE:

Bruker sees FY2024 EPS of $2.36-$2.41, versus the consensus of $2.60. Bruker sees FY2024 revenue of $3.34-3.37 billion, versus the consensus of $3.4 billion.

For earnings history and earnings-related data on Bruker (BRKR) click here.